Page 479 - Binder2
P. 479
(pg. 225) Nature. (2025).
https://www.nature.com/articles/d41573-025-00017-x
(pg. 69) Johnson & Johnson. (2024). Showcase of
hematology portfolio at ASH Annual Meeting.
https://innovativemedicine.jnj.com/us/johnson-johnson-to-
showcase-strength-of-its-broad-hematology-portfolio-and-
pipeline-at-the-2024-american-society-of-hematology-
annual-meeting
(pg. 69) Fierce Pharma. (n.d.). Darzalex Faspro approval
update. https://www.fiercepharma.com/pharma/jj-touts-
new-foundational-frontline-multiple-myeloma-treatment-
darzalex-faspro-nabs
(pg. 37) Association for Accessible Medicines. (2023). U.S.
Generic & Biosimilar Medicines Savings Report.
(pg. 88) Polinski, J. M., et al. (2021). Current Medical
Research and Opinion.
(pg. 119) Gastroenterology. (n.d.). COUR study.
https://www.gastrojournal.org/article/S0016-
5085(21)00521-7/fulltext
(pg. 99) Mungfali. (n.d.). Types of T Cells and Their
Functions [Graphic].https://mungfali.com/explore/Types-
of-T-Cells-and-Their-Function
(pg 180) Tschofen, M., Knopp, D., Hood, E., & Stöger, E.
(2016). Plant molecular farming: Much more than
medicines. Annual Review of Analytical Chemistry, 9, 271–
294. https://doi.org/10.1146/annurev-anchem-071015-
041706
477

